⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Supplemental Table 4 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts

Joanne Kotsopoulos Cassandra A. Hathaway Steven A. Narod Lauren R. Teras Alpa V. Patel Chunling Hu Siddhartha Yadav Fergus J. Couch Shelley S. Tworoger

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplemental Table 4: Mutation frequencies in high grade serous, endometroid, or poorly differentiated ovarian cancer cases and controls and risk of ovarian cancer in the NHS, NHSII, and CPSII

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kotsopoulos et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522c16 https://doi.org/10.1158/1055-9965.27030115.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table 4 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts2024
2Supplemental Table 5 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts2024
3Supplemental Table 5 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts2024
4Supplemental Table 3 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts2024
5Supplemental Table 3 from Germline mutations in 12 genes and risk of ovarian cancer in three population-based cohorts2024